ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $583,000 | +99.0% | 24,500 | -19.7% | 0.04% | +95.7% |
| Q3 2016 | $293,000 | -4.2% | 30,500 | -3.2% | 0.02% | -4.2% |
| Q2 2016 | $306,000 | +39.1% | 31,500 | 0.0% | 0.02% | +26.3% |
| Q1 2016 | $220,000 | +37.5% | 31,500 | 0.0% | 0.02% | +46.2% |
| Q4 2015 | $160,000 | -28.9% | 31,500 | 0.0% | 0.01% | -38.1% |
| Q3 2015 | $225,000 | -4.7% | 31,500 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $236,000 | -16.6% | 31,500 | 0.0% | 0.02% | -16.0% |
| Q1 2015 | $283,000 | -99.9% | 31,500 | -6.0% | 0.02% | +56.2% |
| Q4 2014 | $229,140,000 | +128630.3% | 33,500 | +8.1% | 0.02% | +14.3% |
| Q3 2014 | $178,000 | – | 31,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |